AUG 17, 2019 8:44 AM PDT

New method to stop metastasis in lymph nodes

Research reported recently in ACS Nano explains a new method of targeting metastases in lymph nodes as a means of preventing the spread of cancers. The approach could provide novel treatment methods for patients vulnerable to metastasis, the process during which cancer cells separate from the primary tumor to form tumors at other sites. Metastasis is leading cause of cancer deaths.

This strategy targets lymph nodes because metastatic cancer usually spreads first to these glands through small vessels called lymphatics, which carry immune cells and fluid. While most conventional treatment options utilize biopsies of the lymph nodes to see if metastasis has occurred, taking a biopsy is an invasive procedure that can cause pain and infection. Instead of biopsies, the method developed by researchers Hong-Jun Li, Jin-Zhi Du and colleagues uses a nanoparticle delivery tool, called iCluster.

iCluster is already used as a nanoparticle delivery tool to bring chemotherapies directly to tumors, but by injecting iCluster combined with a red dye into mice with tumors, the researchers figured out that iCluster is also capable of entering a tumor and passing through the lymphatics. Using fluorescent imaging, the scientists saw that this mechanism provides a channel to target the lymph nodes directly and potentially treat metastases.

The study concluded that 40% of the treated mice treated with iCluster were still alive 110 days following the removal of the tumor; in comparison, those mice that did not receive treatment from iCluster before the removal of tumors all died from metastases within 51 days of surgery. Additionally, while the iCluster-treated mice lived longer, they also were seen to have far fewer tumors than untreated mice.

The authors explain their findings, stating, “Here, we uncovered that improved perfusion in a primary tumor facilitates nanoparticle translocation to lymph nodes for inhibiting tumor metastasis. On the basis of our finding that an iCluster platform…markedly improved particle perfusion in the interstitium of the primary tumor, we further revealed in the current study that such tumor-specific size transition promoted particle intravasation into tumor lymphatics and migration into lymph nodes.”

Sources: Science Daily, ACS Nano

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 17, 2021
Clinical & Molecular DX
Delays in Breast Cancer Diagnoses Among Black Women
AUG 17, 2021
Delays in Breast Cancer Diagnoses Among Black Women
Thanks to breakthrough diagnostic technologies, we can now catch the early warning signs of breast cancer much faster th ...
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
OCT 14, 2021
Clinical & Molecular DX
Cancer-Sniffing Worms: The Future of Diagnostics?
OCT 14, 2021
Cancer-Sniffing Worms: The Future of Diagnostics?
Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, i ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
NOV 11, 2021
Cancer
US Military Veterans: Cancer Risk and Cancer Research
NOV 11, 2021
US Military Veterans: Cancer Risk and Cancer Research
The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, ...
Loading Comments...